Sinocare  has 20 years experiences in BGM industry since its foundation in 2002, it is the biggest BGM manufacturing facility company in Asia and the first listed blood glucose meter manufacturer company in China, dedicating to the innovation of biosensor technology, developing, manufacturing and marketing on rapid diagnosis testing products.  In 2016, after the successfully acquisition of Nipro diagnostic Inc. (now renamed as Trividia Health Inc.) and PTS Diagnostics Inc. Sinocare has become the world’s No.5 largest blood glucose meter manufacturer and one of the leading companies in POCT industry in the world.

OPPDRAG

   Ved å tilby produkter og tjenester av høy kvalitet til mennesker med diabetes og andre kroniske sykdommer for å hjelpe dem med å forbedre livskvaliteten.

VISSION

        The Leading Diabetes Digital Management Expert in the World

CARING FOR LOVE

   Tildelt "2022 China Best Employer Enterprises Award"

PROFESSIONAL CERTIFICATION

   Mottatt registreringsbevis for medisinsk utstyr og produksjonsgodkjenning i 2004. Bestått ISO: 13485 av EU TUV og mottatt CE-sertifikat i 2007.

GLOBAL ANERKJENNELSE

   Oppført av Forbes som et av Asias 200 "Beste Under A Billion"-selskap i 2015 som det største BGMS-produksjonsanlegget i Asia.

VERDENSLEDENDE

    Kjøpte verdens sjette blodsukkermålerbedrift. Gikk inn i den ledende leiren til BGMS i verden.

EN LEDER I BRANSEN

    Sinocare Lu Valley Biosensor Manufacturing Facility lokalisert i Changsha National High-Tech Industrial Development Zone ble lansert i 2013. Med rundt 66,000 2 mXNUMX bruttoareal blir fabrikken vår den største produksjonsbasen for blodsukkerovervåkingssystem (BGMS) i Asia.

    Our business covers 135 countries and regions in the world.

    More than 63% OTC share and 130,000 pharmacies in China.

    Our products include blood glucose, blood lipids, blood ketone, glycosylated hemoglobin(HbA1c), uric acid and other diabetes indicators.

A COMMITMENT TO EXCELLENCE

    Som et av demonstrasjonsprosjektene til National Biomedical Engineering High-Tech Industrialization Program, mottok Sinocare økonomisk støtte fra National Innovation Fund i flere ganger, og besto ISO: 13485 sertifisering for kvalitetsstyringssystem og europeisk CE-sertifikat i 2007.

THE METABOLIC DISEASE DETECTION EXPERT

    In the last 20 years, our accurate, affordable, and simple-to-use blood glucose monitoring systems have been well received by all segments of customers across China, with more than 50% of diabetes self-monitoring population using Sinocare products. We can proudly claim that we have successfully educated and promoted the blood glucose self-monitoring for people with diabetes in China.

    However, owning a blood glucose monitoring system is only the first step. To achieve the goal of controlling blood glucose level effectively, people with diabetes need to learn how to test blood glucose, when to test, how frequently to test, and what to do with the data. Besides, how diet and exercise impact the individual blood glucose level needs to be considered as part of equation as well. To help people with diabetes to understand all the important aspects of diabetes management fully aligns with our goal, “From Diabetes Management Expert to Metabolic Disease Detection Expert”.

    This goal motivates everyone at Sinocare: we have delivered blood glucose monitoring systems with more advanced technologies, we have developed multi-analyte analyzers to provide more information about diabetes, we have developed a hospital diabetes management platform to close loop between doctors, patients, dieticians, and diabetes educators. Ultimately, we are going to form a diabetes management eco-system and provide a solution to improve the quality of life for people with diabetes, to simplify the interactions between healthcare providers and patients, and to improve healthcare economy for our society.